Bristol-Myers Squibb buy StockNews.com
Start price
29.07.23
/
50%
€55.90
Target price
29.07.24
-
Performance (%)
-19.63%
End price
30.07.24
€44.93
Summary
This prediction ended on 30.07.24 with a price of €44.93. The price of Bristol-Myers Squibb has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.63%. StockNews_com has a follow-up prediction for Bristol-Myers Squibb where he still thinks Bristol-Myers Squibb is a Buy. Dividends of €2.19 are taken into consideration when calculating the performance. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bristol-Myers Squibb | 3.575% | 3.575% | 38.175% | -0.035% |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
Comments by StockNews_com for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten